Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanisms
- 18 October 2005
- journal article
- Published by Elsevier
- Vol. 15 (3) , 349-362
- https://doi.org/10.1016/s0149-7634(05)80028-4
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Muscarinic receptor differentiationPharmacology & Therapeutics, 1988
- Evidence that Alterations in ?-Aminobutyric Acid and Acetylcholine in Rat Striata and Cerebella Are Not Related to Soman-Induced ConvulsionsJournal of Neurochemistry, 1988
- Acute effects of Soman, Sarin, and Tabun on cyclic nucleotide metabolism in rat striatumJournal of Toxicology and Environmental Health, 1986
- Acute Effects of Soman, Sarin, and Tabun on Microsomal and Cytosolic Components of the Calmodulin System in Rat StriatumJournal of Neurochemistry, 1986
- Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethalityLife Sciences, 1985
- Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepineLife Sciences, 1984
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983
- Modification of cholinergically induced convulsive activity and cyclic GMP levels in the CNSNeuropharmacology, 1983
- New concepts on the mechanism of action of benzodiazepinesLife Sciences, 1975
- Cholinolytics in the treatment of anticholinesterase poisoning. V. The effectiveness of Parpanit with oximes in the treatment of organophosphorus poisoningCanadian Journal of Physiology and Pharmacology, 1968